Teva to commercialise Polpharma’s biosimilar drug
Polpharma Biologics Group’s joint venture has entered into an agreement with Teva to commercialise a biosimilar drug to Ranibizumab. The…
biological drugs
Ioana Parsons to replace Guillaume Delmotte at Ipsen Poland
Ioana Parsons has been appointed General Director of Ipsen Poland. Thus, she has moved from Amgen’s Italian subsidiary to Warsaw….
New Alzheimer’s drug approved in the US
The US Food and Drug Administration (FDA) grants expedited approval to Biogen to market its Alzheimer’s drug in the US. The…
Bioceltix will raise funds for biological drug development
Bioceltix, one of the new hopes in the Polish biotechnology arena, has published an information memorandum stating that it plans…
PMR report: The number of companies on the biological drugs market is growing
According to forecasts presented in the PMR report “Biological and biosimilar drugs market in Poland 2019. Market analysis and development…
Dirk Kreder is the new president of Mabion
Dirk Kreder was appointed president of the Polish biotechnology company Mabion. New president of Mabion Dirk Kreder has extensive experience…
PMR report: Biological medicines market in Poland strongly consolidated
Due to the relatively small number of drugs and the high barriers to entry, the market for biological medicines is…
Reimbursement system in Poland: New therapies since January
The Ministry of Health has announced the introduction of new drugs both in drug programmes and on the pharmacy list…
PMR: Biological medicines market in Poland 2019
PMR presents a set of infographics from the report: Biological and biosimilar medicines market in Poland 2019. Market analysis and development…
PMR report: Impressive growth of biological medicines
According to the forecasts presented in PMR’s latest report “Biological and biosimilar medicines market in Poland 2019. Market analysis and…
